𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1.075 DOES NEUROINFLAMMATION AFFECT DEVELOPMENT OF DEMENTIA IN PATIENTS WITH PARKINSON'S DISEASE?

✍ Scribed by I.-U. Song; Y.-D. Kim; K.-S. Lee

Book ID
117754560
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
54 KB
Volume
18
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Levodopa treatment does not affect low-d
Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease
✍ Svenja Happe; Tobias Tings; Kathrin Helmschmied; Karin Neubert; Wolfgang Wuttke; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 73 KB

## Abstract Challenge with low‐dose apomorphine causes a significant rise in growth hormone (GH) in patients with Parkinson's disease (PD) compared to controls and patients with multiple system atrophy (MSA) who have not previously received dopaminergic treatment. To date, it has not been demonstra

Effect of rivastigmine on tremor in pati
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia
✍ Tanya Y. Gurevich; Herzel Shabtai; Amos D. Korczyn; Ely S. Simon; Nir Giladi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

## Abstract The purpose of this study was to assess whether rivastigmine, a cholinergic agent, affects tremor features when given to improve cognition in demented Parkinson's disease (PD) patients. Demented PD patients (n = 26; Mini‐Mental State Examination score, 13–25; age, 75.2 Β± 4.9 yr) were gi